Dr. Sonis currently serves as clinical professor of oral medicine at Harvard School of Dental Medicine, senior surgeon and chief, divisions of oral medicine at Brigham and Women’s Hospital and the Dana-Farber Cancer Institute, all located in Boston.
Dr. Sonis has collaborated with PlasmaTech Biopharmaceuticals, a biopharmaceutical company, in recent years on advancing the company’s clinical efforts of its oral mucositis treatment, MuGard.
More articles on oral care:
Dr. Jack Singer named Florida Dental Director for LIBERTY Dental Plan
10 dentist leadership moves & honors
Dr. Robert Bitter named ADA trustee
